Related Experiment Video
Updated: May 4, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Centrosomal BRCA2 is a target protein of membrane type-1 matrix metalloproteinase (MT1-MMP)
Nadila Wali1, Kana Hosokawa2, Sadiya Malik2
1Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Japan; Department of Obstetrics and Gynecology, Urumqi Friendship Hospital, Xinjiang, PR China.
Abstract:
BRCA2 localizes to centrosomes between G1 and prophase and is removed from the centrosomes during mitosis, but the underlying mechanism is not clear. Here we show that BRCA2 is cleaved into two fragments by membrane type-1 matrix metalloproteinase (MT1-MMP), and that knockdown of MT1-MMP prevents the removal of BRCA2 from centrosomes during metaphase. Mass spectrometry mapping revealed that the MT1-MMP cleavage site of human BRCA2 is between Asn-2135 and Leu-2136 ((2132)LSNN/LNVEGG(2141)), and the point mutation L2136D abrogated MT1-MMP cleavage. Our data demonstrate that MT1-MMP proteolysis of BRCA2 regulates the abundance of BRCA2 on centrosomes.
Insights
The protein BRCA2 is broken down by MT1-MMP during cell division. This cleavage regulates BRCA2
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The protein BRCA2 (Breast Cancer gene 2) is known to localize to centrosomes during specific cell cycle phases.
- The precise mechanism controlling BRCA2's removal from centrosomes during mitosis remains unclear.
- Centrosomes play critical roles in cell division and organization.
Purpose of the Study:
- To elucidate the mechanism behind BRCA2's regulated removal from centrosomes during mitosis.
- To investigate the role of specific proteases in BRCA2 centrosomal localization.
- To understand how BRCA2 abundance at centrosomes is controlled.
Main Methods:
- Utilized knockdown of membrane type-1 matrix metalloproteinase (MT1-MMP) to assess its effect on BRCA2.
- Employed mass spectrometry to identify the precise cleavage site of BRCA2 by MT1-MMP.
- Generated a point mutation (L2136D) in BRCA2 to abrogate MT1-MMP cleavage.
Main Results:
- Demonstrated that BRCA2 is cleaved into two fragments by MT1-MMP.
- Showed that MT1-MMP knockdown prevents BRCA2 removal from centrosomes during metaphase.
- Identified the MT1-MMP cleavage site in human BRCA2 between Asn-2135 and Leu-2136.
- Confirmed that the L2136D mutation abolishes MT1-MMP-mediated cleavage of BRCA2.
Conclusions:
- MT1-MMP proteolysis is a key mechanism regulating BRCA2 abundance on centrosomes.
- BRCA2 cleavage by MT1-MMP is essential for its proper removal during mitosis.
- This finding provides new insights into cell cycle regulation and centrosome dynamics.
Related Concept Videos
Centrosome Duplication
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
Role of Matrix Metalloproteases in Degradation of ECM
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Microtubule Associated Proteins (MAPs)

